3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rhabdomyosarcoma
5
Wilms Tumor
4
Sarcoma
4
Hydatidiform Mole
2
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma
1
Malignant mesenchymal tumor
1
Lymphoma
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Fibrosarcoma
1
Choroid Plexus Neoplasms
1
Choriocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Blast Crisis
1
Beckwith-Wiedemann Syndrome
1
Interventions
vatalanib
1
romidepsin
1
indolepropanol phosphate
1
Watchful Waiting
1
Sunitinib
1
Sorafenib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Polymerase Chain Reaction
1
Observation
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Ifosfamide
1
Gene Expression Profiling
1
Doxorubicin
1
Blotting, Western
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hemangiopericytoma, Malignant
×
Dactinomycin
×
Clear all
No trials found.